中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

已选(0)清除 条数/页：   排序方式：
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng;  Zou, Dehui;  Li, Wei;  Yang, Haiyan;  Liu, Ting;  Wang, Quanshun;  Lv, Fangfang;  Guo, Haiyi;  Zhao, Xia;  Wang, Dan;  Zhang, Pei;  Wang, Yidi;  Wang, Lei;  Liu, Tengfei;  Zhang, Yun;  Shen, Zhirong;  Huang, Jane;  Zhu, Jun
收藏  |  浏览/下载：44/0  |  提交时间：2022/05/05
A phase 2 study of tislelizumab monotherapy in patients with previously treated, locally advanced unresectable ormetastatic microsatellite instability-high/mismatch repair deficient solid tumors. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Jian;  Xu, Ye;  Zang, Aimin;  Gao, Yunong;  Gao, Quanli;  Zhang, Yanqiao;  Wang, Dong;  Xu, Jianming;  Yuan, Ying;  Jiang, Haiping;  Ying, Jieer;  Shi, Chunmei;  Deng, Yanhong;  Wang, Jing;  Liu, Tianshu;  Huang, Yi;  Li, Zhezhen;  Wang, Huanli;  Liu, Shou;  Shen, Lin
收藏  |  浏览/下载：54/0  |  提交时间：2022/01/10
Tislelizumab (BGB-A317) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL): Long-term follow-up efficacy and safety results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng;  Zou, Dehui;  Li, Wei;  Yang, Haiyan;  Liu, Ting;  Wang, Quanshun;  Lv, Fangfang;  Guo, Haiyi;  Yang, Liudi;  Huang, Jane;  Novotny, William F.;  Wang, Yidi;  Zhu, Jun
收藏  |  浏览/下载：56/0  |  提交时间：2022/01/10